Literature DB >> 7918082

The transport of two iron chelators, desferrioxamine B and L1, across Caco-2 monolayers.

K O Hamilton1, L Stallibrass, I Hassan, Y Jin, C Halleux, M Mackay.   

Abstract

The transport of two iron chelators, desferrioxamine B (DFO) and L1 (1,2-dimethyl-3 hydroxypyridin-4-one) has been studied in vitro using the human adenocarcinoma cell line, Caco-2. The transport of DFO and L1 has also been compared with that of their iron-bound complexes, ferrioxamine (FO) and L1(3)-Fe, respectively. We report an apparent permeability coefficient (Papp) value for DFO of 0.170 x 10(-7) +/- 0.080 cm s-1. The Papp value of L1 was 1.297 x 10(-5) +/- 0.133 cm s-1. The Papp values of their iron bound complexes FO and L1(3)-Fe are 0.230 x 10(-7) +/- 0.065 cm s-1 and 2.356 x 10(-6) +/- 0.365 cm s-1, respectively. We have shown that the transport of DFO and FO is similar in the Caco-2 cell system. The transport of L1, however, is greatly reduced when complexed to iron. The value for total uptake after 60 min for DFO into the Caco-2 cells was 1.49 +/- 0.09 x 10(-3) nmol per filter. The values for total uptake after 60 min for L1 and L1(3)-Fe were 0.37 +/- 0.03 nmol per filter and 0.04 +/- 0.01 nmol per filter, respectively. Our results indicate that the poor oral bioavailability of DFO can be attributed to the low epithelial permeability of the molecule coupled with its size (mol wt 656). In contrast, the oral bioavailability observed with L1 is due to the high lipophilicity and low molecular weight (mol wt 139) of the molecule. We believe that these differences between the two molecules account for L1 being better orally absorbed than DFO.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918082     DOI: 10.1111/j.1365-2141.1994.tb04841.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Transport kinetics of iron chelators and their chelates in Caco-2 cells.

Authors:  Xi-Ping Huang; M Spino; J J Thiessen
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

3.  Development of a sensitive HPLC method to measure in vitro permeability of E- and Z-isomeric forms of thiosemicarbazones in Caco-2 monolayers.

Authors:  Zufan Debebe; Sergei Nekhai; Meseret Ashenafi; David B Lovejoy; Danuta S Kalinowski; Victor R Gordeuk; W Malcolm Byrnes; Des R Richardson; Pradeep K Karla
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-08-15       Impact factor: 3.205

4.  Effects of iron chelates on the transferrin-free culture of rat dermal fibroblasts through active oxygen generation.

Authors:  N Yabe; H Matsui
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.723

5.  Nitric oxide induces hypoxia ischemic injury in the neonatal brain via the disruption of neuronal iron metabolism.

Authors:  Qing Lu; Valerie A Harris; Ruslan Rafikov; Xutong Sun; Sanjiv Kumar; Stephen M Black
Journal:  Redox Biol       Date:  2015-06-23       Impact factor: 11.799

Review 6.  Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.

Authors:  Vassilena Iankova; Ivan Karin; Thomas Klopstock; Susanne A Schneider
Journal:  Front Neurol       Date:  2021-04-15       Impact factor: 4.003

7.  Desferrioxamine decreases NAD redox potential of intact red blood cells: evidence for desferrioxamine as an inducer of oxidant stress in red blood cells.

Authors:  Yutaka Niihara; Junli Ge; Oded Shalev; Huiyuan Wu; Amy Tu; Kouichi R Tanaka
Journal:  BMC Clin Pharmacol       Date:  2002-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.